Strategic CDMO BePharBel Manufacturing functions as an end-to-end CDMO under European GMP for small molecules, sterile and non-sterile formulations, offering development, manufacturing, analytical services, procurement support, packaging and serialization. This creates opportunity to position them as a single partner for pharma companies seeking streamlining of development-to-market processes.

Specialized Delivery Their patented MMCR multi-layer micro-particle controlled release platform enables development of controlled release syrups to aid swallowing-impaired patients, presenting a differentiator for pediatric and elderly populations. Potential sales angle: partner on patient-centric formulations and access to innovative delivery systems.

Eyes and Skin Focus With a portfolio in ophthalmology and dermatology as a Marketing Authorisation Holder and a focus on Rx, OTC and dietary supplements in Belgium and Luxembourg, there are cross-sell opportunities to expand product lines within regional markets and leverage regulatory know-how for local launches.

Scale-Ready Capabilities Revenue range indicates a small-to-mid-sized operation with flexible capacity, which can appeal to mid-stage and niche pharma players seeking cost-efficient development and manufacturing without the overhead of large CDMOs. Emphasize scalable manufacturing and rapid onboarding.

Tech and Partnerships Utilizes modern tech stack and partner-ready capabilities (GMP-compliant development, serialization, procurement support, and analytical services) to enable faster time-to-market. Position as a lean partner for collaborative development projects, clinical batch manufacturing, and regulatory submissions in the EU.